Metis Global Partners LLC Sells 2,073 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Metis Global Partners LLC reduced its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 13.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 13,909 shares of the medical device company’s stock after selling 2,073 shares during the quarter. Metis Global Partners LLC’s holdings in Cooper Companies were worth $1,279,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in COO. Fulton Bank N.A. grew its stake in shares of Cooper Companies by 3.0% during the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after acquiring an additional 109 shares during the period. Mather Group LLC. grew its stake in shares of Cooper Companies by 7.4% during the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after acquiring an additional 133 shares during the period. MassMutual Private Wealth & Trust FSB grew its stake in shares of Cooper Companies by 15.6% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after acquiring an additional 136 shares during the period. Greenleaf Trust grew its stake in shares of Cooper Companies by 5.0% during the 4th quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after acquiring an additional 139 shares during the period. Finally, UMB Bank n.a. grew its stake in shares of Cooper Companies by 22.5% during the 4th quarter. UMB Bank n.a. now owns 773 shares of the medical device company’s stock valued at $71,000 after acquiring an additional 142 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently issued reports on COO. Morgan Stanley cut their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Citigroup cut their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Finally, Wells Fargo & Company upped their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, Cooper Companies currently has a consensus rating of “Moderate Buy” and an average price target of $117.22.

Cooper Companies Stock Up 1.4 %

Shares of COO opened at $91.65 on Tuesday. The stock has a market capitalization of $18.29 billion, a price-to-earnings ratio of 47.00, a price-to-earnings-growth ratio of 2.25 and a beta of 1.00. The business’s 50 day simple moving average is $92.63 and its 200-day simple moving average is $99.59. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.04. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.87 earnings per share. As a group, equities analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.